Stockreport

Olema Pharmaceuticals CEO Spotlights Phase 3 Palazestrant Trials, KAT6 Program at Citi Summit [Yahoo! Finance]

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF Olema Pharmaceuticals CEO Spotlights Phase 3 Palazestrant Trials, KAT6 Program at Citi Summit [Read more]